These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 27261580)
1. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN. Zhu DY; Li XN; Qi Y; Liu DL; Yang Y; Zhao J; Zhang CY; Wu K; Zhao S Biomed Pharmacother; 2016 Jul; 81():79-85. PubMed ID: 27261580 [TBL] [Abstract][Full Text] [Related]
2. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients. Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231 [TBL] [Abstract][Full Text] [Related]
5. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway. Yang WB; Zhang WP; Shi JL; Wang JW Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192 [TBL] [Abstract][Full Text] [Related]
6. miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN. Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS Int J Clin Exp Pathol; 2015; 8(4):3827-34. PubMed ID: 26097565 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN. Ren P; Gong F; Zhang Y; Jiang J; Zhang H Tumour Biol; 2016 Mar; 37(3):3215-25. PubMed ID: 26432332 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner. Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN. Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Liu ZL; Wang H; Liu J; Wang ZX Mol Cell Biochem; 2013 Jan; 372(1-2):35-45. PubMed ID: 22956424 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951 [TBL] [Abstract][Full Text] [Related]
13. MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma. Song C; Lu P; Shi W; Sun G; Wang G; Huang X; Wang Z; Wang Z Biomed Pharmacother; 2016 Oct; 83():843-849. PubMed ID: 27501502 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN. Li H; Huhe M; Lou J Biomed Res Int; 2021; 2021():7590976. PubMed ID: 34307670 [TBL] [Abstract][Full Text] [Related]
15. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197 [TBL] [Abstract][Full Text] [Related]
16. Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer. Wang J; Chen H; Liao Y; Chen N; Liu T; Zhang H; Zhang H Tumour Biol; 2015 Sep; 36(9):6965-72. PubMed ID: 25861022 [TBL] [Abstract][Full Text] [Related]
17. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer. Zhu J; Zhang Y; Yang X; Jin L Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208 [TBL] [Abstract][Full Text] [Related]
18. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer. Liu F; Cai Y; Rong X; Chen J; Zheng D; Chen L; Zhang J; Luo R; Zhao P; Ruan J Mol Cancer; 2017 Jul; 16(1):122. PubMed ID: 28716024 [TBL] [Abstract][Full Text] [Related]
19. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer. Li W; Cui Y; Wang D; Wang Y; Wang L Biochem Biophys Res Commun; 2019 Feb; 509(3):647-656. PubMed ID: 30611568 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer. Chen SW; Wang TB; Tian YH; Zheng YG Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]